| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
a Belfast City Hospital, Belfast, Northern Ireland; b Irish Cancer Society, Dublin, Ireland and c Irish Association for Nurses in Oncology, Dublin, Ireland
Correspondence: Ms. Eileen Dillon, Clinical Research Nurse, Northern Ireland Cancer Clinical Trials Unit, East Podium, C Floor, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, Northern Ireland. Telephone: 44-2890-263903; Fax: 44-2890-263897; e-mail: eileen.dillon{at}bch.n-i.nhs.uk
| ABSTRACT |
|---|
|
|
|---|
Key Words. Cancer • Fatigue • Quality of life • Current management
| INTRODUCTION |
|---|
|
|
|---|
When I feel normal, I can plan my life more than a day ahead. I can take on challenges. I can enjoy being with people instead of finding them annoying. I can enjoy physical activities such as yoga and swimming. I can think straight and express myself clearly. I can, most importantly, take responsibility for my own life.
It took Mary 2 hours to fill in the fatigue questionnaire, and afterward, she expressed gratitude for the opportunity to share her experience of fatigue with someone.
The objectives of the All Ireland Fatigue Surveys, conducted under the auspices of the All Ireland Fatigue Coalition (AIFC), are to learn more about the nature of cancer patients fatigue, to explore the impact that fatigue has on the life of cancer patients, to determine physicians and nurses perceptions of cancer fatigue, and to find the current level of management of fatigue on the island of Ireland. Three separate survey instruments on fatigue were designed: one for physicians, one for nurses, and one for patients. Questionnaires were mailed to a sample of two professional groups in Northern Ireland and the Republic of Ireland: physicians and oncology nurses. The physicians came from a number of different specialties: hematology, medical oncology, radiation oncology, clinical oncology, palliative care, and surgical oncology. In the professional surveys, 109 physicians and 160 nurses participated.
The third component of the survey focuses on patients. Participants for the patients survey are currently being recruited in Northern Ireland and the Republic of Irelandspecifically in the Belfast City Hospital, which incorporates Belvoir Park Hospital, The Marie Curie Centre in Belfast, and St. Jamess and St. Lukes Hospitals in Dublin. Recruitment will begin in Galway at the University College Hospital in the near future. Patients are recruited by direct request when they attend their investigators clinic. The target recruitment number is 400500 patients. The results of the patient survey in this report come from the first 143 patients recruited (Table 1
).
|
| RESULTS OF SURVEYS TO DATE |
|---|
|
|
|---|
In contrast, nearly half the patients (41%) reported fatigue as the side effect that affected them the most during treatment. Only 12% of patients reported that nausea affected them the most and only 8% reported that hair loss affected them the most (Fig. 1
). When patients were asked which side effect affected them the most after treatment, fatigue was again reported as affecting them the most (39%), again followed by nausea (12%) and hair loss (4%). These findings suggest that physicians and nurses are underestimating the impact that cancer-related fatigue has on their patients. The fact that the nurses ranked fatigue as the second most significant side effect, while physicians ranked fatigue third, suggests that the nurses may have had a somewhat greater understanding of fatigues impact on cancer patients.
|
The patients themselves reported that they discussed their fatigue with physicians and nurses to a similar extent, although more than 15% of patients did not discuss their fatigue with anyone. When discussing diagnosis and treatment options, more than half the patients reported that fatigue was mentioned as a possible side effect following treatment, but only 29% of patients reported that fatigue-relieving strategies were discussed with them.
Effects of Fatigue on Patients Lives
Eighty-four percent of patients reported having fatigue of some sort. Fifty-five percent actually experienced fatigue every day or on most days. When asked how long their bouts of fatigue lasted, 18% of patients reported that their bouts of fatigue lasted less than 1 day. Of this 18%, however, more than one quarter reported that fatigue had a significant effect on their lives. The survey also revealed that the longer the bouts of fatigue lasted, the more significant was the overall impact of fatigue on respondents lives.
"No energy," "tired," and "exhaustion" were the most common expressions used by patients who described their fatigue (Fig. 2
). These expressions were closely followed by "cant do what I used to do" and, in descending order, "lack of interest," "no drive to do anything," "not feeling good," "irritable," "headaches and body aches," and "ailments." Others included "poor concentration," "need to sit and rest," "a bit down," and "memory loss."
|
|
The survey also addressed patients employment status preceding diagnosis and the changes that they had made as a result of fatigue. Of the respondents who were self-employed or working full time for an employer, 52% had accepted fewer responsibilities, 44% had reduced the number of hours that they worked, and over half (54%) had found it necessary to stop working altogether.
It is important to note that the patients fatigue also affects the caregivers. Of these, 34% took days off, 22% accepted fewer responsibilities than they normally would have accepted, 23% reduced the number of hours that they worked, and 8% had to stop work altogether. One caregiver actually lost a business. These results indicate that cancer-related fatigue has an economic impact on cancer patients lives.
Treatments to Relieve Fatigue
This survey also examined the treatment of fatigue and revealed that over half of the physicians believed that fatigue was something that patients must live with. In comparison, the majority of nurses (70%) believed that fatigue was something that could be relieved. According to the survey, more nurses than physicians reported that they had prescribed treatments to relieve patients of fatigue. Unfortunately, the professional survey indicates that approximately half the patients who experienced fatigue and reported it to their physician or nurse, received no treatment to relieve their fatigue.
Physicians and nurses reported that their number one recommendation for patients experiencing fatigue was rest, followed closely by exercise. More nurses than physicians reported recommending diet and complementary therapy for patients who experienced fatigue. More physicians than nurses, not surprisingly, reported recommending prescription drugs and erythropoietin for such patients (Fig. 4
).
|
|
| CURRENT AND FUTURE PLANS |
|---|
|
|
|---|
The AIFC is promoting the proactive management of cancer-related fatigue in Irish cancer patients through professional education, patient awareness and education, and patient advocacy.
The patient and professional surveys, whose initial findings are reported in this paper, are an important first step in assessing needs and developing solutions. The professional surveys reported in this paper were conducted with physicians and oncology nurses from the North and South, and these are completed. The teams are now in the process of extending professional surveys to include other disciplines whose professionals are involved in the care of cancer patients, including physiotherapy, occupational therapy, dietetics, and clinical psychology. The patient surveys are still in process. The interim data for this paper came from 143 patients: 127 from Northern Ireland and 16 from the Republic of Ireland. The goal is to have data from a total of 400500 patients, fairly evenly distributed between the North and South.
The Irish Association for Nurses in Oncology (IANO) is one organization that is taking a leading role to promote professional development in the area of cancer fatigue. With its four regional branches, the IANO has a considerable network of nurses around Ireland to begin to address these issues and has plans to focus first on nurse education, with patient education and awareness following in the next year. Think-tank sessions and workshops that will help to identify nurses educational needs in regard to cancer-related fatigue will be the first step in nurse training. The Training the Trainers model, from the Learning to Live with Cancer Program developed by Professor Gertrud Grahn of Lund University in Sweden, may be the model used by the IANO, as it has been used successfully in the past. Nurses involved in palliative care nursing, in addition to oncology nurses, will be involved in the training, as they have important roles to play in the management of fatigue. With regard to patient awareness, the IANO has links with the European Oncology Nursing Society and with the Oncology Nursing Society in America and will be looking at the models that these groups have used successfully, with the intent to share information and learn from colleagues who have developed initiatives abroad. In addition, the Irish Cancer Society has recently re-edited a version of the CancerBACUP patient education booklet on cancer-related fatigue with an unrestricted educational grant from Ortho Biotech and has begun distribution to all oncology units throughout the country. This will be a very helpful tool in expanding awareness of fatigue, useful for patients and caregivers alike. Copies of the booklet are available free of charge from the Irish Cancer Society.
| CONCLUSION |
|---|
|
|
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. Poirier Policy Implications of the Relationship of Sick Leave Benefits, Individual Characteristics, and Fatigue to Employment During Radiation Therapy for Cancer Policy Politics Nursing Practice, November 1, 2005; 6(4): 305 - 318. [Abstract] [PDF] |
||||
![]() |
U. Reinhardt, A. Tulusan, R. Angermund, H. Lutz, and For The German Epoetin Alfa Study Group Increased Hemoglobin Levels and Improved Quality-of-Life Assessments During Epoetin Alfa Treatment in Anemic Cancer Patients: Results of a Prospective, Multicenter German Trial Oncologist, March 1, 2005; 10(3): 225 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Daly Introduction: All Ireland Fatigue Coalition Oncologist, February 1, 2003; 8(90001): 1 - 2. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |